NASDAQ: MRVI Investor Presentation June 2025 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may, from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this presentation which are not strictly historical statements constitute forward-looking statements, including, without lim ...

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- This release corrects and replaces the version distributed earlier today at 16:05 ET. The original version inc ...

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of lifescience reagents and services to ...

NASDAQ: MRVI Q1 2025 Financial Results May 12, 2025 Agenda | 01 | Welcome | Deb Hart, Head of Investor Relations | | --- | --- | --- | | 02 | Business Highlights | Trey Martin, Chief Executive Officer | | 03 | Financial Results | Kevin Herde, Chief Financial Officer | | | & Guidance | | | 04 | Q&A Session | Trey Martin, Chief Executive Officer Kevin Herde, Chief Financial Officer | | | | Becky Buzzeo, Chief Commercial Officer | © 2025 Maravai LifeSciences 2 Forward Looking Statements and Use of Non-GAAP Fin ...

SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2025, together with other business updates. Financial Highlights: Quarterly revenue of $46.9 million, Net loss of $(52.9) million (including a goodwill impairment of $12.4 million), and Adjusted EBITDA of $(10.5) million; andRevenue ...

Maravai LifeSciences (MRVI) FY 2023 Conference November 16, 2023 09:00 AM ET Speaker0 Good afternoon. Thanks for being here at the last session of our London conference. We're very excited to have Maribai Life Sciences with us today here to tell us more about the story before we jump into some Q and A, CEO, Trey Martin as well as CFO, Kevin Hurti. Turn it over to Trey. Speaker1 All right. Thank you. Thanks for being here in person. I know it sounds like we're at the tail end of this conference. And also tha ...